2021-06-02

Added · Updated

Commission Delegated Regulation (EU) 2021/1456 on fair, reasonable, non-discriminatory and transparent clearing terms for OTC derivatives

The European Commission specifies the conditions under which commercial terms for clearing services for OTC derivatives are considered fair, reasonable, non-discriminatory, and transparent. This Regulation applies to clearing service providers in the Union regarding OTC derivative contracts subject to the clearing obligation, requiring them to disclose onboarding processes, use standardized request forms, and base fees on objective criteria. Providers must conduct risk assessments using specific criteria, provide written reasons for refusals or suspensions, and allow a minimum six-month notice period for contract termination or material changes. Existing commercial terms agreed before 9 September 2021 must be reviewed and modified to meet these requirements by 9 September 2022.

European Commission logo

European Union

European Commission

Scan of the document's first page
Share

Get EC alerts — same-day email on every new publication.

Read the rest free, and get an email when EC publishes again

Lineage: In force

Regulation (EU) No 648/2012 of …2012Regulation (EU) 2019/834 of the…2019Commission DelegatedRegulation (EU) 2021/1456 on …2021-06-02 · this document
amendssupersedesissued underrefers toproposed or not in RegAlertarrows run from the older text to the one that changes it

Source: European Commission — original document · Summary generated with machine assistance and reviewed before publication; the authoritative text is the regulator's original document. How RegAlert works

More like this from EC

We email you every new EC publication the day it's published.